Clincal observation of Semen Juglandis combined with arterial embolization in treatment of benign prostatic hyperplasia

doi:10.3877/cma.j.issn.2095-5782.2018.01.009

Abstract

Abstract:

Objective:

To evaluate the feasibility and efficacy of Semen Juglandis combined with prostatic arterial embolization in the treatment of benign prostatic hyperplasia (BHP) .

Methods:

From January 2012 to November 2006, 10 patients with BPH were treated with arterial embolization. On the day after operation, the patients were administered with 2 g Semen Juglandis after being infused in hot water or decoction, 3 times/d, for 7 d. The changes of international prostate symptom score (IPSS) , quality of life score (QOL) , maximum urinary flow rate (Qmax) and residual urine (RU) preoperative and postoperative 1 month were compared. Another comparison is made between preoperative and postoperative 6 months.

Results:

Ten patients underwent embolization of 16 prostate artery, 4 cases of unilateral embolism and 6 cases of bilateral embolization. Compared with preoperative indexes, in postoperative 6 months, IPSS was significantly improved [ (28.30±3.27) vs. (4.40±1.17) , P<0.05], and QOL was significantly improved (5.10±1.52 vs. (1.00±0.47) , P<0.05]; Qmax was significantly improved [ (7.05±2.72) vs. (15.08±1.45) , P<0.05], and RU was significantly reduced [ (120.00±70.18) vs. (17.50±7.55) , P<0.05].

Conclusions:

Semen Juglandis combined with prostatic arterial embolization is feasible and effective for treating BHP.

Key words: Benign prostatic hyperplasia, Prostate embolization, Semen Juglandis, Interventional radiology

Hu Shen, Lei Zhu, Xiaoping Pan. Clincal observation of Semen Juglandis combined with arterial embolization in treatment of benign prostatic hyperplasia[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2018, 06(01): 37-39.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2018.01.009

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2018/V06/I01/37

Figures/Tables 3

References 7

[1]	Rosena RC, Carson CC. Sexual dysfunction and lower urinary tract symptoms（LUTS）associated with benign prostatic hyperplasia （BPH）[J]. European Urology, 2005, 47(6):824.
[2]	周学鲁，周上军，占平, 等．中药白芨用于前列腺动脉栓塞治疗良性前列腺增生的临床研究[J/CD].中华介入放射学电子杂志, 2017, 5(2):89-93. doi：10.3877/cma.j.issn.2095-5782.2017.02.008.
[3]	邓健，韩耕宇，许卫国，等．前列腺动脉介入栓塞治疗前列腺增生症的临床评价[J].现代泌尿外科杂志，2013，18(1):60-62. doi：10.3969/j.issn.1009-8291.2013.01.025.
[4]	谢宗贵，孙钢．前列腺增生的动脉栓塞治疗[J].中华放射学杂志，2004，38(3):321-322.
[5]	《全国中草药汇编》编写组．全国中草药汇编:上册[M]．第2版.北京:人民卫生出版社，2000：686.
[6]	高莉，王艳梅，帕提古丽·马合木提．核桃分心木粗提物抑菌活性的研究[J]．食品科学，2008，29(11):69-71.
[7]	张慧玲．分心木泡服补中益气丸治疗前列腺术后小便频作34例[J].陕西中医，2012，33(7):864-865.doi：10.3969/j.issn.1000-7369.2012.07.066

时间	IPSS（分）	QOL（分）	Qmax(ml/s)	RU(ml)
术前	28.30±3.27	5.10±1.52	7.05±2.72	120.00±70.18
术后1个月	9.20±1.55^a	2.00±0.82^a	11.01±1.59^a	39.50±11.68^a
术后6个月	4.40±1.17^a	1.00±0.47^a	15.08±1.45^a	17.50±7.55^a
F值	331.559	42.790	40.206	12.523
P值	<0.01	<0.01	<0.01	0.001

时间	IPSS（分）	QOL（分）	Qmax(ml/s)	RU(ml)
术前	28.30±3.27	5.10±1.52	7.05±2.72	120.00±70.18
术后1个月	9.20±1.55^a	2.00±0.82^a	11.01±1.59^a	39.50±11.68^a
术后6个月	4.40±1.17^a	1.00±0.47^a	15.08±1.45^a	17.50±7.55^a
F值	331.559	42.790	40.206	12.523
P值	<0.01	<0.01	<0.01	0.001

[1]	Gangwei Han, Xueqing Shen, Hanxiao Wu, Yanwu Cao, Liming Tang. Comparison of clinical effect of transurethral vaporization using diode laser and plamakinetic resction without resectoscope shealth for benign prostate hyperplasia with mild urethral stricture [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(05): 490-494.
[2]	Lianghai Lai, Wei Zhao, Yunxin Xiao, Weiming Yang, Guangyao Chen. A comparative study of 1 470 nm laser "mean trichotomy " enucleation of the prostate and transurethral plasmakinetic enucleation for benign prostatic hyperplasia [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(03): 252-256.
[3]	Song Wan, Wei Hua, Hongmei Lan, Zhengxin Luo, Yueping Wan. Comparison of the clinical efficacy of holmium laser enucleation and transurethral resection of the prostate for benign prostatic hyperplasia [J]. Chinese Journal of Endourology(Electronic Edition), 2022, 16(05): 427-431.
[4]	Yi Dong, Meng Yang, Zheng Wang, Ai'min Jiang, Zongqin Zhang, Zhenjie Wu, Linhui Wang, hong Xu, Bing Liu. Clinical experiences and efficacy of plasmakinetic anatomical enucleation of the prostate with cylindrical electrode [J]. Chinese Journal of Endourology(Electronic Edition), 2022, 16(05): 413-418.
[5]	Ning Zhang, Mengfei Zhang, Jianxin Qiu, Yanyao Gao, Yu Chen, JingYu Gao. Laparoscopic transurethral plasma resection combined with mesh plug tension-free hernioplasty in treating inguinal indirect hernia with benign prostatic hyperplasia in elderly patients [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(04): 441-444.
[6]	Yili Han, Jiahui Zhao, Yong Luo, Mingchuan Li, Dechao Wei, Yongguang Jiang. Transperitoneal approach robotic-assisted simple prostatectomy for benign prostatic hyperplasia: initial experience [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2022, 15(02): 106-109.
[7]	Chao Zhang, Tao Luo, Ang Li, Linzhong Zhu, Dongbin Liu, Dongdong Lin, Fei Li, Guokun Ao. Clinical value of interventional diagnosis and therapy of iatrogenic massive hemobilia [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2023, 11(03): 212-217.
[8]	Chengzhi Zhang, Yanli Wang, Xuhua Duan, Xinwei Han, Pengli Zhou, Dechao Jiao. Application of QR code scanning technology for undergraduate during interventional radiology clinical practice [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2023, 11(01): 74-77.
[9]	Xueqing Huang, Zheyu Jiang, Min Xu, Shi Zhou, Lizhou Wang. The application of simulation teaching in the teaching reform of interventional radiology micro course [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(03): 316-319.
[10]	Liteng Lin, Wensou Huang, Zhaoxiong Guo, Minhong Li, Chaowei Lie, Jingwen Zhou, Kangshun Zhu, Xi Li. Evaluation of PBL combined with PDCA teaching method in the clinical training of advanced interventional radiologists [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(03): 312-315.
[11]	Yi Chen, Lei Li, Rong Wang, Chao Zhao, Duiping Feng. The effect of superselective prostatic arterial embolization in the treatment of recurrent benign prostatic hyperplasia after TURP [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(02): 185-189.
[12]	Jiali Lin, Zhuting Fang. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia: a review [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(01): 65-69.
[13]	Jianzhuang Ren, Wenguang Zhang, Fan Tang, Pengfei Chen, Linhui Xu, Fangzheng Li, Donglin Kuang, Guohao Huang, Mengfan Zhang, Dechao Jiao, Xinwei Han. "Six in one" interventional radiology training mode exploration for advanced students of the First Affiliated Hospital of Zhengzhou University [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(01): 90-92.
[14]	Zhongxiao Yan. Comparative study on transurethral holmium laser resection and plasmakinetic resection in treatment of benign prostatic hyperplasia in elderly patients [J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2022, 09(03): 42-45.
[15]	Qingfeng Tang, Xiaoke Huang, Chengwan Liu, Weiqi Lai, Liang Li. Clinical analysis of low-powered holmium laser enucleation of prostate for benign prostatic hyperplasia in elderly patients [J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2022, 09(03): 37-41.

Please choose a citation manager

Content to export